第十一批集采19个抗感染药备战!倍特、石药、科伦蓄势待发,5个超15亿大品种“被盯上”

米内网
04 Jun

精彩内容近期,国家及地方相继召开会议,提及启动第十一批国家药品集采。作为国采主力军,全身用抗感染化药2024年在中国公立医疗机构终端销售额约1230亿元,同比下滑12.68%;品牌TOP10方面,辉瑞的注射用头孢哌酮钠舒巴坦钠(2:1)、东阳光药的磷酸奥司他韦颗粒、海南海灵化学制药的注射用拉氧头孢钠等高居前五。19个全身用抗感染化药备战第十一批集采,其中5个品种销售额超15亿元;倍特药业、齐鲁制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10